KNTE - Kinnate Biopharma GAAP EPS of -$0.68 beats by $0.08
2023-08-08 17:57:31 ET
- Kinnate Biopharma press release ( NASDAQ: KNTE ): Q2 GAAP EPS of -$0.68 beats by $0.08 .
- As of June 30, 2023, total cash, cash equivalents and investments were $204.3 million, which is expected to fund current operations into early 2025.
For further details see:
Kinnate Biopharma GAAP EPS of -$0.68 beats by $0.08